Search for: "Novartis Pharmaceuticals Inc"
Results 41 - 60
of 393
Sort by Relevance
|
Sort by Date
22 Mar 2020, 5:42 am
Sun Pharmaceutical Industries, issuing a temporary injunction, stopping Sun Pharmaceuticals from launching its generic version of Novartis’ Nilotinib. [read post]
3 Mar 2020, 4:00 am
In Novartis Pharmaceuticals Canada Inc. v. [read post]
30 Jan 2020, 10:49 am
In January 2019, Illinois reached a $135 million settlement with Teva Pharmaceuticals, and in October, the state reached a $242 million settlement with more than a dozen different drug makers, including Abbot Laboratories, Aventis, GlaxoSmithLine, Johnson & Johnson, McNeil, Novartis, and more. [read post]
24 Jan 2020, 10:24 am
Also tagged in this scheme were Novartis, Dendreon, Onyx, Questcor, and Bayer. [read post]
11 Jun 2019, 7:43 am
[Watch Here] Today’s witnesses are primarily business leaders and in-house attorneys for large IP-focused businesses: Panel I Manny Schecter, Chief Patent Counsel at IBM Laurie Self, Senior Vice-President and Counsel at Qualcomm Byron Holz, Senior Counsel at Nokia Kim Chotkowski, VP at InterDigital Sean Reilly, Associate General Counsel at The Clearing House Payments Company Panel II Laurie Hill, VP for IP at Genentech Sean George, CEO at Invitae Gonzalo… [read post]
14 May 2019, 11:24 am
USA, Inc., 566 F.3d 989, 994(Fed. [read post]
18 Apr 2019, 9:43 pm
Par Pharmaceutical Inc., District Judge Richard G. [read post]
15 Apr 2019, 7:19 pm
Par Pharmaceutical Inc., Nos. 14-1289-RGA, 14-1494-RGA, 15-0078-RGA (D. [read post]
2 Mar 2019, 9:48 pm
Breckenridge Pharmaceutical, and Supernus Pharmaceuticals, Inc. v.... [read post]
22 Feb 2019, 3:48 am
Novartis AG v. [read post]
20 Dec 2018, 10:14 am
” See Novartis Pharmaceuticals Corp. v. [read post]
11 Dec 2018, 9:46 pm
The first, Novartis AG v. [read post]
7 Dec 2018, 2:23 pm
The outcome was reversal; Novartis wins:Novartis Pharmaceuticals Corporation and NovartisAG (collectively, Novartis) appeal the district court’sdecision to invalidate U.S. [read post]
30 Jun 2018, 2:01 am
Andrews in Novartis Pharmaceuticals Corp. et al. v. [read post]
29 Jun 2018, 7:50 am
Amphastar Pharmaceuticals, Inc. [read post]
3 May 2018, 11:19 am
Canadian doctors were advised to closely monitor their Tasigna patients for signs of the life-threatening artery disease.Here is the link for the Canada label changes made in 2013:Subject: Updated information regarding the possible risk of developing atherosclerosis-related conditions with the use of TASIGNA* (nilotinib)Novartis Pharmaceuticals Canada, Inc. [read post]
6 Mar 2018, 2:10 pm
We are doing this review because it was during April 2013 that Novartis Pharmaceuticals Canada Inc. took these actions: Sent a so-called "Dear Doctor" letter in Canada (but not the US) warning about some serious side effects associated with Tasigna; and, Issued a Tasigna drug label change in Canada (but not the US) with new information concerning those Tasigna side effects. [read post]
6 Mar 2018, 2:10 pm
In closing this article, I will point out that as of today, nearly five years after the actions taken by Novartis Pharmaceuticals Canada Inc., in the US there still has not been any "Dear Doctor" letter nor any Tasigna drug label change made by Novartis Pharmaceuticals Corporation similar to what was done in Canada during April 2013. [read post]
27 Feb 2018, 9:12 am
Relevant parts of this April 9, 2013 letter from Novartis Pharmaceuticals Canada Inc. are set forth below: Dear Healthcare Professional: Subject: Updated information regarding the possible risk of developing atherosclerosis-related diseases with the use of TASIGNA* (nilotinib) Novartis Pharmaceuticals Canada Inc. [read post]
21 Feb 2018, 7:45 pm
Torrent Pharmaceuticals (here) The PTAB’s Institution Decision in Novartis denied grounds including a prior art reference known as “Sakai. [read post]
